Cardiac pacing and valvular surgery.
Over a 17-year period (1970-1987) 75 patients, 3% of overall valvular surgery (VS) patients have been permanently paced at the time of VS (group 1), nine have been paced long after (group 2), 12 were already paced at the time of valve replacement (group 3), and 81 had a permanent pacing lead inserted during VS without further need for permanent pacing (group 4). Based on pre-, per- and post-operative clinical and electrocardiographic data we studied these four groups (GR). Aortic disease and especially calcified aortic stenosis (CAS) are the main valvular pathologies in all GR. The survival rate in GR 1 is lower than the survival rate of our overall VS PT5 due to older average ages and more severe cardiac conditions. In five patients GR 2 a myocardial pacing lead placed during VS was used long after for permanent stimulation. Patients in GR 3 were older than in other GR at the time of VS. The mortality was high in the patients operated on between 1973 and 1978 (average survived 3.5 years after pacing/2 years after VS) thus demonstrating the benefit of myocardial protection. For GR 4 the ratio of permanent lead implantation during VS was high in the late seventies (10%), it is now around 0.5%. In cases where the evolution of peroperative conduction disturbances is doubtful, it seems to us simpler to place a myocardial lead avoiding subsequent endocardial pacing if necessary, later, especially in patients with tricuspid disease.
Gaillard
D
D
Hôpital Saint-Joseph, Paris, France.
Lespinasse
P
P
Vanetti
A
A
D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006349:Heart Valve Diseases / Q000628:therapy*; D006350:Heart Valve Prosthesis / Q000401:mortality; D006801:Humans; D007430:Intraoperative Care; D008297:Male; D008875:Middle Aged; D010138:Pacemaker, Artificial / Q000401:mortality; D011184:Postoperative Period